SkyDance Vascular Publishes Paper in JAVA on Groundbreaking Peripheral Intravenous Catheter (PIVC) Design

Skydance Vascular Study Shows a Reduction in Insertion-Related Contamination in an Ovine Study DELRAY BEACH, FLORIDA, UNITED STATES, March 21, 2023 /EINPresswire.com/ — Skydance Vascular, a medical device company that re-imaged the Peripheral Intravenous Catheter (PIVC), has released the findings of a research paper titled “The Potential Role of through the Needle PIVC Insertion in […]
Skydance Vascular Successfully Closes Initial Seed Round

Innovative startup reshaping the Peripheral Intravenous Catheter (PIV) market closes seed financing round of $2.5M. DELRAY BEACH, Florida (October 27, 2020) – SkyDance Vascular (SkyDance) today announced the completion of their initial seed funding round, securing $2.5M through private investments. The startup, founded in 2017, has reimagined the Peripheral Intravenous Catheter (PIV) designed to reduce the […]
Skydance Vascular Secures $3.3 Million In Additional Seed Funding

Innovative startup will further accelerate the safety of Peripheral Intravenous Catheters DELRAY BEACH, Florida (December 14, 2021) – SkyDance Vascular (“SkyDance” or “the Company”), a newly formed medical device company dedicated to reimagining the Peripheral Intravenous Catheter (PIV), today announced that it has closed $3.3 million in additional seed funding from a combination of existing and […]
Skydance Vascular Announces Issuance Of New U.s. Patent

New patent provides additional safety measures for the use of Peripheral Intravenous Catheters (PIV) DELRAY BEACH, Florida (November 16, 2021) – SkyDance Vascular (“SkyDance” or “the Company”), a newly formed medical device company dedicated to reimagining the Peripheral Intravenous Catheter (PIV), today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice […]
The Million Dollar Question

A more comprehensive approach to the assessment and reporting of all hospital-onset bacteremia was a major topic at this year’s Association for Vascular Access Scientific Meeting. We learned from Michelle DeVries, MPH, CIC, VA-BC lecture “Beyond CLABSI; Considering Hospital Onset Bacteremia,” that current literature supports moving beyond just CLABSI to more robust surveillance that includes peripheral […]
Skydance Vascular Successfully Closes Initial Seed Round

Innovative startup reshaping the Peripheral Intravenous Catheter (PIV) market closes seed financing round of $2.5M. DELRAY BEACH, Florida (October 27, 2020) – SkyDance Vascular (SkyDance) today announced the completion of their initial seed funding round, securing $2.5M through private investments. The startup, founded in 2017, has reimagined the Peripheral Intravenous Catheter (PIV) designed to reduce the […]
Better Blood Culture Tests Equal Better Patient Care | Reposted from LinkedIn

Live interview with Barbara DeBaun and Nancy C. Caralla from C Diff Foundation on VoiceAmerica discussing how better blood culture tests equal better patient care, fewer antibiotics, and less C.difficile. For full story click here Reposted from LinkedIn / Barbara DeBaun and Nancy C. Caralla. / October 2020.
Skydance Vascular Launches New Website In Support Of Fund Raising Efforts

Innovative startup reshaping the Peripheral Intravenous Catheter (PIV) market lays out current challenges and groundbreaking solution to a critical healthcare procedure. SkyDance Vascular (SkyDance), a company established to transform the market for Peripheral Intravenous Catheters (PIV), today announces the debut of a new website, www.skydancevascular.com, aimed at supporting its upcoming fund raising efforts. The new site comprehensively identifies […]
Skydance Vascular And Thasis Partner For Fund-raising Initiatives And Launch Strategy

Innovative startup to introduce a newly designed catheter looking to reduce infection rates and complications from usage. SkyDance Vascular (SkyDance), a company aiming to transform the market for Peripheral Intravenous Catheters (PIV), has engaged Thasis LLC (Thasis) to assist with its fund-raising strategy and develop the appropriate marketing communications, platforms, and materials to clearly represent […]